.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Baxter
Cipla
Novartis
Fish and Richardson
Johnson and Johnson
Chubb
Chinese Patent Office
McKesson

Generated: July 26, 2017

DrugPatentWatch Database Preview

Temazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for temazepam and what is the scope of temazepam freedom to operate?

Temazepam
is the generic ingredient in three branded drugs marketed by Duramed Pharms Barr, Actavis Elizabeth, Mylan, Sandoz, Watson Labs, Quantum Pharmics, Novel Labs Inc, Mallinckrodt Inc, Sun Pharm Inds, Prinston Inc, Amneal Pharms, and Usl Pharma, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for temazepam. Thirty-eight suppliers are listed for this compound.

Summary for Generic Name: temazepam

Tradenames:3
Patents:1
Applicants:12
NDAs:22
Drug Master File Entries: see list7
Suppliers / Packagers: see list38
Bulk Api Vendors: see list15
Clinical Trials: see list6
Patent Applications: see list5,590
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:temazepam at DailyMed

Pharmacology for Ingredient: temazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL201781-001Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL078581-001Sep 8, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
TEMAZEPAM
temazepam
CAPSULE;ORAL070920-003Jun 12, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-004Nov 2, 2004ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan
TEMAZEPAM
temazepam
CAPSULE;ORAL070920-002May 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: temazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-003Oct 25, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Deloitte
Fish and Richardson
Chubb
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot